Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Ronot

Showing results (321-330 of 391) with videos related to

Pageof 40
Sort By:
Journal of Hepatology|December 25, 2019
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCsAnita Paisant, Valérie Vilgrain, Jérémie Riou, et al.
European Radiology|September 5, 2024
MRI-based prediction of the need for wide resection margins in patients with single hepatocellular carcinomaYanshu Wang, Yali Qu, Chongtu Yang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 7, 2026
Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT ScansCeline Sin, Martin Luther Watzenboeck, Eugenia Iofinova, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosisPierre Nahon, Marie Najean, Richard Layese, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2023
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT studyFrank Kolligs, Dirk Arnold, Rita Golfieri, et al.
European Radiology|December 20, 2024
MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC ≤ 5 cm: a multicenter cohort studyHanyu Jiang, Binrong Li, Tianying Zheng, et al.
Radiology. Imaging Cancer|January 6, 2023
Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial TreatmentJessica Assouline, Roberto Cannella, Giorgia Porrello, et al.
European Heart Journal|October 23, 2018
The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohortIsabelle D Munsterman, Anthonie L Duijnhouwer, Timothy J Kendall, et al.
JACC. Cardiovascular Imaging|May 20, 2019
Impact of Liver Diseases on Heart and LungsAnne-Lise Hachulla, Pierre-Emmanuel Rautou, Stéphanie Franchi-Abella, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up of primary malignant liver tumoursPierre Nahon, Christophe Aubé, Lucile Moga, et al.
Pageof 40

Showing results (321-330 of 391) with videos related to

Sort By:
Pageof 40
Journal of Hepatology|December 25, 2019
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCsAnita Paisant, Valérie Vilgrain, Jérémie Riou, et al.
European Radiology|September 5, 2024
MRI-based prediction of the need for wide resection margins in patients with single hepatocellular carcinomaYanshu Wang, Yali Qu, Chongtu Yang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 7, 2026
Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT ScansCeline Sin, Martin Luther Watzenboeck, Eugenia Iofinova, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2022
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosisPierre Nahon, Marie Najean, Richard Layese, et al.
JHEP Reports : Innovation in Hepatology|January 3, 2023
Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT studyFrank Kolligs, Dirk Arnold, Rita Golfieri, et al.
European Radiology|December 20, 2024
MRI-based prediction of microvascular invasion/high tumor grade and adjuvant therapy benefit for solitary HCC ≤ 5 cm: a multicenter cohort studyHanyu Jiang, Binrong Li, Tianying Zheng, et al.
Radiology. Imaging Cancer|January 6, 2023
Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial TreatmentJessica Assouline, Roberto Cannella, Giorgia Porrello, et al.
European Heart Journal|October 23, 2018
The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohortIsabelle D Munsterman, Anthonie L Duijnhouwer, Timothy J Kendall, et al.
JACC. Cardiovascular Imaging|May 20, 2019
Impact of Liver Diseases on Heart and LungsAnne-Lise Hachulla, Pierre-Emmanuel Rautou, Stéphanie Franchi-Abella, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up of primary malignant liver tumoursPierre Nahon, Christophe Aubé, Lucile Moga, et al.
Pageof 40